PharmD · Ohio
Collaborative Practice Agreement for Pharmacists in Ohio
Yes, a written physician agreement is required. Ohio calls it a Consult Agreement.
Four distinct, physician/protocol-gated pathways — none is a broad standing-order or population-level authority the way some other states allow. Whether Ohio pharmacists may furnish hormonal contraceptives without a prescription is genuinely disputed between two secondary trackers (Guttmacher says no as of 4/17/2026; NASPA, dated later, lists Ohio as yes but with no citation); coded as NOT currently authorized since no enacting statute could be located for either position. PrEP/PEP furnishing is confirmed NOT authorized.
Independent practice requires: Consult Agreement (Ohio Rev. Code §4729.39, OAC 4729:1-6-02) — per-patient, per-diagnosis drug therapy management with a physician/PA/CNS/CNM/CNP who already has an ongoing relationship with that patient for that diagnosis; valid up to 2 years; OR immunization authority (§4729.41) for ages ≥13 under a physician-established protocol; OR naloxone dispensing (§4729.44) under a physician- or local-health-board-established protocol (no statewide standing order in Ohio); OR (eff. 1/1/2026) epinephrine dispensing without a prescription (§4729.47) under a protocol established by a physician OR — per the 2025 'Global Signature' law, SB 196 — a CNM/CNS/CNP.
What the collaboration must look like
The rules the physician relationship has to follow. Each fact comes from the statute or board rule listed under sources.
Proximity
Not codified — left to the agreement
Supervision ratio
Not codified — no cap on file
Chart review
Not codified — left to the agreement
Meeting cadence
Not codified — left to the agreement
Prescriptive authority
Separate prescribing terms required · controlled substances permitted
Requires state board controlled-substance registration and DEA registration (with limited hospital-institutional exceptions), plus an OARRS report covering ≥1 year reviewed before adding any controlled substance to a patient's regimen. Schedule II specifically: a pharmacist may not modify the prescribed drug at all except for legally permitted substitutions or correcting the prescriber's signature/patient's name — any other change requires prescriber consultation.
Written agreement
Required
True for all three pathways — a physician-originated document (consult agreement, or physician/health-department protocol) is required in every verified scope-expansion; there is no default independent scope beyond core dispensing/counseling.
Practice ownership (corporate practice of medicine)
Non-licensee ownership permitted — A pharmacy's 'terminal distributor of dangerous drugs' (TDDD) license can reportedly be held by an individual, partnership, LLC, or corporation regardless of pharmacist licensure — but a licensed pharmacist must separately be named as the 'responsible person' (Ohio Rev. Code §4729.54/§4729.55), bearing statutory responsibility for drug safeguards/records, and may serve as responsible person for only one pharmacy absent special board permission. This functionally constrains operational control even where equity ownership isn't restricted.
Could not confirm a clean statutory statement either allowing or barring non-pharmacist EQUITY ownership specifically — the responsible-person requirement is confirmed, but whether it implies an ownership restriction too is unresolved.
Legal sources for these rules (8)
- Ohio Rev. Code §4729.39 — Consult agreements
- OAC 4729:1-6-02 — Consult agreement requirements (via Cornell LII mirror, read directly)secondary
- Ohio Rev. Code §4729.41 — Adult immunizations
- Ohio Rev. Code §4729.44, OAC 4729:1-3-04 — Naloxone dispensing
- Ohio Rev. Code §4729.47 — Epinephrine dispensing without a prescription, eff. 1/1/2026, confirmed verbatim in a follow-up passsecondary
- SB 196 (2025, 'Global Signature' law) — extends epinephrine-protocol authority to CNM/CNS/CNPsecondary
- Ohio Rev. Code §4729.54, §4729.55 — TDDD licensing, 'responsible person' requirement
- Guttmacher Institute — pharmacist-prescribed-contraceptives tracker (as of 4/17/2026, Ohio NOT listed) — conflicts with a NASPA resource (dated later, through 7/9/2026) listing Ohio with no citation; a candidate enacting bill (H.B. 248) could not be confirmed as ever passed across 5 General Assemblies of reintroduction — unresolved, coded conservatively
What a collaborating physician costs here
Typical monthly cost in Ohio
$500 – $600
Estimate for one Pharmacist. Standard-tier state.
About Ohio's rules
Ohio recently relaxed CRNA supervision from 'immediate presence' to facility-wide 'collaboration' (H.B. 52, eff. 6/8/2026, now current law), and will loosen RN laser-delegation rules similarly (H.B. 377, eff. 8/25/2026 — NOT yet law as of this file's date). No independent-practice pathway exists for NP/PMHNP/PA despite active pending reform bills (a 2,000-hour NP threshold, PA proximity removal) — none enacted. Ohio has no corporate-practice-of-medicine doctrine (State Medical Board, 2012). Non-nurse midwifery has no current licensure pathway.
Other clinicians in Ohio: see the state overview.